Importantly, the liver-specific cytostatic effect of Smad4 reactivation was confirmed in the GEMMs, where short-term (7-day) Smad4 restoration reduced the percentage of Ki67+ tumor cells in liver metastases but not in primary tumors or lung metastases (Extended Data Fig. 4d). The gene discussed is MKI67; the disease is neoplasm.